Option Care Health (NASDAQ:OPCH) Sees Unusually-High Trading Volume on Strong Earnings

Option Care Health, Inc. (NASDAQ:OPCH) shares saw unusually-high trading volume on Tuesday following a stronger than expected earnings report. Approximately 1,565,199 shares were traded during mid-day trading, an increase of 27% from the previous session’s volume of 1,232,796 shares.The stock last traded at $30.46 and had previously closed at $30.41.

The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.04. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The firm had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same period last year, the company earned $0.21 earnings per share. The firm’s revenue for the quarter was up 12.8% on a year-over-year basis.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Jefferies Financial Group raised their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th. Barrington Research restated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the company’s stock in a transaction on Monday, February 26th. The shares were bought at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the transaction, the director now owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Option Care Health

Several hedge funds have recently modified their holdings of OPCH. Vontobel Holding Ltd. lifted its holdings in shares of Option Care Health by 2.9% in the third quarter. Vontobel Holding Ltd. now owns 13,168 shares of the company’s stock valued at $426,000 after buying an additional 374 shares during the period. IFP Advisors Inc grew its stake in shares of Option Care Health by 20,350.0% in the 3rd quarter. IFP Advisors Inc now owns 2,454 shares of the company’s stock worth $79,000 after purchasing an additional 2,442 shares during the last quarter. SG Americas Securities LLC lifted its stake in Option Care Health by 1,638.4% during the third quarter. SG Americas Securities LLC now owns 84,729 shares of the company’s stock valued at $2,741,000 after purchasing an additional 79,855 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in Option Care Health by 4.3% during the third quarter. State of Alaska Department of Revenue now owns 21,376 shares of the company’s stock valued at $691,000 after purchasing an additional 880 shares during the last quarter. Finally, Avior Wealth Management LLC boosted its holdings in Option Care Health by 30.5% during the third quarter. Avior Wealth Management LLC now owns 15,706 shares of the company’s stock worth $508,000 after buying an additional 3,670 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Performance

The stock has a market cap of $5.09 billion, a price-to-earnings ratio of 19.27, a price-to-earnings-growth ratio of 1.74 and a beta of 1.22. The company’s 50-day simple moving average is $32.04 and its 200-day simple moving average is $31.50. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.